
1. vaccine. 2006 jun 12;24(24):5140-8. epub 2006 may 2.

multigenotype hcv-ns3 recombinant vaccinia viruses model evaluation of
cross-genotype immunity induced hcv vaccines mouse.

eisenbach c(1), freyse a, lupu cm, weigand k, ernst e, hoyler b, stremmel w,
bugert jj, encke j.

author information: 
(1)university heidelberg, department gastroenterology, hepatology,
infectious diseases intoxications, im neuenheimer feld 410, d-69120
heidelberg, germany.

surrogate infections hcv-recombinant vaccinia viruses (hcv-rvv) a
standard method test efficacy hepatitis c virus (hcv) vaccine
candidates mouse model. established panel 16 hcv-rvv expressing
the nonstructural protein 3 (ns3) hcv genotypes 1a, 1b, 2, 3 4. mice
immunized recombinant ns3 protein derived hcv genotype 1b were
challenged rvv. rvv-titers decreased 54-fold subtype 1b
challenge 8.5-fold subtype 1a challenge. change detected
for genotype 2, 3, 4. model convenient reliable tool analyze
the induction cross-genotype immunity experimental vaccination mice.

doi: 10.1016/j.vaccine.2006.04.013 
pmid: 16713033  [indexed medline]

